Department of Nuclear Medicine, Christian Medical College, Vellore, India.
Department of Radiation Oncology, Christian Medical College & Hospital, Vellore, India.
Cancer Rep (Hoboken). 2021 Jun;4(3):e1333. doi: 10.1002/cnr2.1333. Epub 2021 Mar 3.
Head and neck squamous cell carcinoma (HNSCC) accounts for 90% of head and neck cancers. There has been no established qualitative system of interpretation for therapy response assessment using PET-CT for HNSCC.
To assess response evaluation of nodal status in post-treatment PET-CT scans in HNSCC using a 5-point Likert scale (Deauville score [DS]).
Retro-prospective analysis was performed of the nodal status of pre and post-RT PET-CT in patients diagnosed with HNSCC (n = 43) from May 2013 to March 2018. All eligible patients underwent a pre-RT PET-CT scan before the start of RT. Another post-RT PET-CT scan was performed 12 weeks after the completion of RT. The median time from completion of radiotherapy (RT) to post-RT PET-CT was 92 days; 80% of the patients had their post-RT PET-CT scan between 77 and 147 days after therapy. Of 43 patients (M/33, F/10, age range 18 to 80 years (median 54 years) selected for the study, good concordance was noted between DS and clinical response in these patients. The change in SUV from pre-RT PET to post-RT PET was analyzed using a paired t-test. The P-value was found to be statistically significant while comparing pre and post-RT SUVmax levels showing that RT had significantly reduced the SUVmax levels of the nodes in DS 2-3 groups whereas the number of patients was too small to allow a reliable calculation in DS 4-5 groups. It was found that 36/39 patients with DS 1-3 had no nodal recurrence showing a high NPV of 92.3%. Of the four patients with DS 4-5, all had active disease showing PPV of 100%. Applying Fisher's exact test, the P-value was found to be .004.
DS seems to satisfy the requirements for a simple qualitative method of interpreting PET scans and for identifying patients requiring neck dissection. Consensus regarding qualitative assessment would facilitate standardization of PET reporting in clinical practice and enable comparative multicentric studies.
头颈部鳞状细胞癌(HNSCC)占头颈部癌症的 90%。目前尚没有针对 HNSCC 治疗反应评估的 PET-CT 解读的定性系统。
使用 Deauville 评分(DS)评估 HNSCC 治疗后 PET-CT 扫描中淋巴结状态的反应评估。
对 2013 年 5 月至 2018 年 3 月期间诊断为 HNSCC 的患者(n=43)的治疗前和治疗后 RT-PET-CT 的淋巴结状态进行了回顾性分析。所有符合条件的患者在 RT 前均进行了治疗前 PET-CT 扫描。在 RT 完成后 12 周进行另一次治疗后 PET-CT 扫描。从放疗(RT)完成到治疗后 PET-CT 的中位时间为 92 天;80%的患者在治疗后 77 至 147 天之间进行了治疗后 PET-CT 扫描。在 43 名患者(男性 33 例,女性 10 例,年龄 18 至 80 岁(中位数 54 岁)中,DS 与这些患者的临床反应之间存在良好的一致性。使用配对 t 检验分析了从治疗前 PET 到治疗后 PET 的 SUV 变化。比较 SUVmax 水平的 P 值具有统计学意义,表明 RT 显著降低了 DS 2-3 组的 SUVmax 水平,而 DS 4-5 组的患者数量太少,无法进行可靠的计算。发现 36/39 名 DS 1-3 患者无淋巴结复发,NPV 为 92.3%。在 DS 4-5 的 4 名患者中,所有患者均有活动性疾病,PPV 为 100%。应用 Fisher 确切检验,P 值为.004。
DS 似乎满足了 PET 扫描解读的简单定性方法的要求,也可以识别需要进行颈部清扫术的患者。定性评估的共识将有助于 PET 报告在临床实践中的标准化,并能够进行比较多中心研究。